John William Branch, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1130 Cottonwood Creek Trl Ste D4, Cedar Park, TX 78613 Phone: 512-551-5500 Fax: 512-551-5509 |
Todd Robert Shepler, M.D. Ophthalmology - Ophthalmic Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 11901 W Parmer Ln, 400, Cedar Park, TX 78613 Phone: 512-528-1144 Fax: 512-528-1143 |
Amy Neuhoff Robertson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 12171 W Parmer Ln, Ste 201, Cedar Park, TX 78613 Phone: 512-528-1144 Fax: 512-528-1143 |
Ms. Pooja Godara, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 925 Starwood Dr., Cedar Park, TX 78613 Phone: 512-327-7000 Fax: 512-259-3802 |
Dr. Ami Amar Shah Vira, MD Ophthalmology - Ophthalmic Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 N Lakeline Blvd Ste 100, Cedar Park, TX 78613 Phone: 512-553-9545 |
Dr. Vincent Anthony Restivo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 12171 W Parmer Ln, Suite 201, Cedar Park, TX 78613 Phone: 512-528-1144 Fax: 512-528-1143 |
Dr. Chaitanya Indukuri, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 13625 Ronald Reagan Blvd, Bldg 9, Ste 100, Cedar Park, TX 78613 Phone: 512-856-5645 |
Dr. Theresa Ebanks Wagner, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 925 Starwood Dr, Cedar Park, TX 78613 Phone: 512-327-7000 Fax: 512-259-3802 |
News Archive
Heart disease is an independent risk factor for severe adverse skin reactions in patients taking allopurinol, found a study published in CMAJ (Canadian Medical Association Journal).
Autism and mercury advocacy organization SafeMinds regrets today's ruling by the U.S. Court of Federal Claims against three families who argued that vaccines which contained the mercury-based preservative thimerosal contributed to their child's autism.
Retrophin, Inc. today announced that it will acquire privately-held Kyalin Biosciences, Inc., an early-stage company based in San Diego, CA, that is developing therapies targeting the core symptoms of autism and related conditions.
HemCon Medical Technologies, Inc., an innovative developer of advanced medical products, is proud to announce the signing of an exclusive licensing agreement with Zeria Pharmaceuticals Co. Ltd., a leading pharmaceutical and consumer healthcare products company. Through this partnership, Zeria will market, distribute, and sell HemCon's line of revolutionary wound and oral care dressings throughout Japan.
› Verified 3 days ago